Exc h-f-nk-sp b9+marg 1.1-2
CPT 11422 covers the surgical removal of a benign (non-cancerous) skin growth on the head, face, neck, hands, feet, or genitals when the lesion measures between 1.1 and 2.0 centimeters in diameter, including the margins removed around it.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Measure the excised diameter including margins, not just the visible lesion—this is the dimension that determines code selection. Document the measurement in the operative note before excision.
Impact: Coding 11422 instead of 11421 (0.6-1.0 cm) increases Medicare reimbursement by approximately $30-40; incorrect downcoding to 11421 costs $30+ per claim
Verify anatomic location qualifies for the head-face-neck-hands-feet-genitalia (h-f-nk-sp) designation; trunk/arms/legs use different code series (11401-11406) with lower reimbursement
Impact: CPT 11422 pays $174.35 vs. 11402 (trunk/extremities, same size) pays approximately $145-155; incorrect location coding creates $20-30 loss per procedure
Bill only one code per lesion regardless of closure complexity; layered repairs are included in the excision code for benign lesions and cannot be separately billed
Impact: Attempting to bill separate repair codes (12xxx series) with benign excisions triggers NCCI edits and automatic denials; avoid compliance risk
When billing multiple excisions in one session, list the largest/most complex excision first without modifier 51, then append modifier 51 to subsequent codes in descending RVU order
Impact: Proper sequencing maximizes reimbursement under MPPR; first procedure pays 100% ($174.35), subsequent procedures pay 50% ($87.18 each)
Distinguish benign (114xx series) from malignant (116xx series) based on clinical suspicion at time of excision, not final pathology; recoding based on pathology results is appropriate if malignancy is confirmed
Impact: Malignant excision codes (11642 for same size/location) reimburse at $265+ vs. $174.35 for 11422; update coding when pathology contradicts clinical diagnosis
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.